Lexiscan Nuclear Stress Test Global Analysis & Forecast to 2024 Lexiscan Nuclear Stress Test Market - Global Indus

Lexiscan Nuclear Stress Test Market - Global
Industry Analysis, Size, Share, Growth, Trends,
and Forecast 2016 - 2024
Lexiscan or regadenoson is a stress agent, which typically works by increasing blood
flow in the arteries of the heart. Lexiscan is specifically used for radionuclide
myocardial perfusion imaging (MPI) in patients who are unable to bear adequate
exercise stress. In this test, typically, patients are asked to walk on a treadmill or
ride a stationary bicycle. The aim is to increase patient’s heart rate until it is
adequately stressed.
The heart is a specified muscle and like other muscles in the body it needs oxygen
and nutrients so that it can continuously pump blood throughout the body.
Regadenoson is injected intravenously in preparation with a radiologic (X-ray)
examination of blood flow through the myocardial perfusion imaging (MPI) nuclear
stress test or coronary artery test.
This 195 page report gives readers a comprehensive overview of the
Thermic Fluids market Browse through 3 data tables and 30 figures to
unlock the hidden opportunities in this market.
http://www.transparencymarketresearch.com/lexiscan-nuclear-stress-test-
market.html
On April 10, 2008, Lexiscan was approved by the U.S. Food and Drug Administration
(FDA). It is marketed by Astellas Pharma. It is approved in the EU under the name
Rapiscan. Currently, it is being marketed by GE Healthcare, which is being sold
mainly in the United Kingdom (U.K.) and Germany.
MPI test is taking pictures of the blood flow in a patient’s heart. This test provides
detailed anatomical images which can be used to diagnose and evaluate conditions
in coronary artery disease. Coronary artery disease progresses when arteries
become damaged or diseased. Usually, coronary arteries are damaged when they
are accumulated with deposits called plaques. Shortness of breath is a usual
indication of coronary artery disease. MPI test images can tell a doctor if a patient’s
heart is bloated and can measure its overall functioning, for example ejection
fraction.